CClinicalTrials.gg
CompletedNCT05807568MISSEDUpdated Feb 11, 2026

MIStreatment Screening in Elders Before Discharge

An interventional study of NCAEM EM-SART Pre-Screen in Elder Abuse, Surveys and Questionnaires and Self Neglect, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this study is to demonstrate the feasibility of introducing, implementing, and integrating a brief, existent elder mistreatment screening tool (the National Collaboratory to Address Elder Mistreatment (NCAEM)'s Elder Mistreatment - Screening And Response Tool (EM-SART) Pre-Screen) in the Memorial Herman Hospital (MHH)-Texas Medical Center (TMC)Acute Care of Elders(ACE) (MHH-TMC ACE) unit and to identify older adults who may already be suffering from abuse, neglect, and/or financial exploitation, as well as connecting the study participants to the primary Geriatric Medicine team on the ACE unit such that additional care, evaluation (including additional in-depth mistreatment screening), and intervention can be taken to prevent and minimize further harm prior to discharge. The investigators hope to reduce missed opportunities for mistreatment detection to lead to safer health outcomes and hospital discharges.

02

Conditions studied

  • Elder Abuse
  • Surveys and Questionnaires
  • Self Neglect
  • Geriatrics
  • Geriatric Assessment
  • Health Services for the Aged
  • Aged

Keywords

  • Elder Mistreatment
  • Abuse
  • Neglect
  • Exploitation
  • Screening
  • Geriatric
  • Questionnaire
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • current admission to the MHH-TMC ACE unit
  • ability to independently hear, understand, and verbally answer the 3 participant questions on the NCAEM's EM-SART Pre-Screen screening tool when it is read to them

Exclusion criteria

Exclusion Criteria:

  • unwillingness to participate in the research study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    NCAEM EM-SART Pre-Screen

    Other: NCAEM EM-SART Pre-Screen

Interventions

  • OtherNCAEM EM-SART Pre-Screen

    Participants will be verbally asked the 3 participant questions on the NCAEM EM-SART Pre-Screen either directly or with support of hospital approved telephonic interpreters. Answers will be documented by the investigator digitally. Participants will be interviewed one time for a duration of approximately 15 minutes. No further action will be taken on study participants with negative elder mistreatment screens, unless findings concerning for emotional distress are identified by the investigator. If emotional distress is identified, these observations will be communicated to Geriatric Medicine team in person or via secure/encrypted email, with recommendations to follow-up with the participant about the results and take appropriate care actions. Study participants with positive elder mistreatment will have results shared with the study participant directly and with the Geriatric Medicine primary team via secure/encrypted email.

06

What researchers measure

Primary outcomes

  1. Number of units using this NCAEM EM-SART Pre-Screen tool

    How many times the NCAEM EM-SART Pre-Screen tool is attempted with consented patients

    Time frame: 12 months after study

  2. Number of participants who have identified elder mistreatment

    Study participants screening positive based on NCAEM EM-SART Pre-Screen tool

    Time frame: 15 minute evaluation of each participant, no follow-up

07

Study locations

1 site
  • The University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05807568
Lead sponsor
The University of Texas Health Science Center, Houston
Responsible party
Julia A Hiner (Assistant Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Apr 11, 2023
Start date
Apr 10, 2023
Primary completion
Feb 2, 2026
Completion
Feb 2, 2026
Last update
Feb 11, 2026

Study contacts

Julia A Hiner, MD
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion